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We conducted a population-based prospective cohort study in Denmark to investigate associations between the personality traits
and cancer survival. Between 1976 and 1977, 1020 residents of the Copenhagen County completed a questionnaire eliciting
information on personality traits and various health habits. The personality traits extraversion and neuroticism were measured using
the short form of the Eysenck Personality Inventory. Follow-up in the Danish Cancer Registry for 1976–2002 revealed 189 incidents
of primary cancer and follow-up for death from the date of the cancer diagnosis until 2005 revealed 82 deaths from all-cause in this
group. A Cox proportional-hazards model was used to estimate the hazard ratios (HRs) of death from all-cause according to
extraversion and neuroticism adjusting for potential confounding factors. A significant association was found between neuroticism and
risk of death (HR, 2.3 (95% CI¼1.1–4.7); Linear trend P¼0.04) but not between extraversion and risk of death (HR, 0.9 (0.4–1.7);
Linear trend P¼0.34). Similar results were found when using cancer-related death. Stratification by gender revealed a strong positive
association between neuroticism and the risk of death among women (Linear trend P¼0.03). This study showed that neuroticism is
positively associated with cancer survival. Further research on neuroticism and cancer survival is needed.
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Psychological traits may alter immune and endocrine function and
it has long been hypothesised that, through this pathway,
personality traits may affect cancer incidence and survival (Spiegel
and Kato, 1996; Kiecolt-Glaser and Glaser, 1999; Dalton et al,
2002). The results of our earlier prospective cohort studies,
however, do not support the hypothesis that personality traits
measured by the Eysenck questionnaire are associated with risk for
cancer (Schapiro et al, 2001; Nakaya et al, 2003; Hansen et al,
2005).
The role of personality traits in cancer survival has been
controversial. Five studies have investigated associations between
personality traits and cancer survival. Two studies found
statistically significant associations (Hislop et al, 1987; Ratcliffe
et al, 1995) but three other studies found no association
between personality traits and risk of death in cancer patients
(Greer et al, 1979; Dean and Surtees, 1989; Nakaya et al, 2005).
However, four studies had several limitations, including failure
to control for cigarette smoking or alcohol consumption, and
failing to assess personality traits before the cancer diagnosis
(Greer et al, 1979; Hislop et al, 1987; Dean and Surtees, 1989;
Ratcliffe et al, 1995).
We conducted a population-based prospective cohort study in
Denmark to further investigate associations between the person-
ality traits and cancer survival. This study focused on personality
traits measured before the cancer diagnosis, and the study to our
knowledge included the second highest number of cancer cases
and deaths of the studies conducted until now.
MATERIALS AND METHODS
Study cohort
All persons born 1936 and living in four municipalities in a
suburban area of Copenhagen in 1976 (n¼1198 persons) were
invited to participate in an epidemiologic health survey at the
Glostrup Population Studies. The survey included a social-
psychiatric interview (Hollnagel et al,1 9 8 1 ) .O ft h e s e ,1 0 5 2p e r s o n s
(88%), equally distributed by sex, accepted the invitation. In a study,
the study population was found to be representative of the age
group 40 years in Copenhagen County (Hollnagel et al, 1981).
Assessment of personality traits and other characteristics
The social-psychiatric interview lasted approximately 1h and was
performed by a physician. The questionnaire included marital
status, socioeconomic status, smoking habits, alcohol consump-
tion, personality, and the presence of symptoms of a psychiatric
disease as evaluated by the interviewing doctor (Sælan and Garde,
1979). Personality traits were measured using a short form of the
Eysenck Personality Inventory (EPI-Q) (Eysenck and Eysenck,
1965) consisting of 18 items (Floderus, 1974). This abbreviated
version, the EPI-Q allows measurement of two dimensions: degree
of extraversion and degree of neuroticism (Schapiro et al, 2001).
Extraversion represents sociability, liveliness, and surgency and
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sneuroticism represents emotional instability, and anxiousness
(Eysenck and Eysenck, 1975).
Linkage to registries
Data on all members of the study population were linked to the
Central Population Register for verification of the personal
identification number and for information on vital statistics and
migration. The Central Population Register in Denmark was
established on 1 April 1968, and all Danish residents are assigned a
10-digit personal identification number, which incorporates sex
and date of birth and permits accurate linkage of information
among registries. Subsequently, the study cohort was linked to the
Danish Cancer Registry, which began reporting cancer incidence
on a nationwide scale in 1943. Each record includes the personal
identification number, date of diagnosis of the tumor, and
information on the tumor. Tumors are coded according to a
modified Danish version of the International Classification of
Diseases, Seventh Revision (Jensen et al, 1985). Finally, the study
cohort was linked to the Danish Registry of Causes of Death, which
holds individual records of deaths in Denmark from 1943 and
onwards (Juel and Helweg-Larsen, 1999). Cause of death was coded
according to a modified Danish version of the International
Classification of Diseases, Tenth Revision.
Follow-up
From the 1052 persons in the study, we excluded 21 persons who
had foreign citizenship as well as persons who had not completed
the extraversion and neuroticism scales leaving 1020 persons.
Members of the cohort were followed for cancer from the date of
social-psychiatric interview, until the date of first cancer (other
than non-melanoma skin cancer), date of emigration, date of
death, or 31 December 2002. This resulted in a total of 189 cancer
cases left for analysis and this subcohort was then followed-up for
death from the date of the cancer diagnosis until date of
emigration, date of death, or the end of the study period (31
January 2005). The 189 cancer cases (65 men and 124 women) of
this study accrued approximately 1704 person-years of follow-up,
with an average of 6 years. A total of 82 deaths from all causes (37
men and 45 women) were observed during follow-up. 84% of the
deaths observed were cancer related, 16% were related to other
causes. No deaths were classified as suicide.
Statistical analysis
The objective of the current analyses was to determine the effect of
extroversion and neuroticism on cancer survival. The personality
subscales were included both as linear as well as ordinal variables.
When using them as ordinal variables the scores on each
personality subscale (score 0–9) were divided into three score
levels approximately equal in size and as a result, the cutoff scores
vary with the subscale. Hazard ratios (HRs) were computed as the
death rate among subjects in each personality score level divided
by the death rate among subjects in the lowest score level. A Cox
proportional-hazard model was used to estimate HRs for
extraversion and neuroticism. We used the SAS PHREG procedure
in the SAS version 8.2 statistical software package (Cary, NC, USA)
(Rothman and Greenland, 1998). All P-values were two-tailed.
First, we tested which of a number of potential demographic and
medical factors to include as confounding variables in the analyses.
Then we performed univariate analyses (adjusted for sex and age
at cancer diagnosis), as well as multivariate analyses (adjusted for
potential confounders shown to have a statistically significant
effect on survival). In addition to sex and age at cancer diagnosis
(continuous variable), we considered the following variables as a
priori confounders: cancer site (digestive organs, hormone-related
organs, virus and immune-related organs, respiratory organs, or
other organs) (World Health Organization, 1992; Schapiro et al,
2001); clinical stage (in situ, localised, regional invasion, distant
metastasis, or unknown); length of education in years (o10, or
410); marital status (living with spouse, or living without spouse);
social class (I–II, III–IV, or V); smoking status at baseline (never
smokers, past smokers, or current smokers); alcohol consumption
in grams of alcohol per week at baseline (0, 1–150 or 151 or more);
and psychiatric status at time of interview (normal, neurotic, or
deviant/psychotic). The social class variable was based on a
classification constructed by the Social Research Institute in
Denmark and is based on a combination of information on
ownership of land, education, employment status, and number of
subordinates. Social group I is the highest social group. The
alcohol consumption variable was computed using the following
definitions: one glass of beer or one glass of wine amounts to 12g
of alcohol, one glass of schnapps or other liqueur amounts to 9g of
alcohol. To test if there was a dose–response relationship between
the personality subscales and cancer survival we did trend tests
using the personality subscales as linear variables. We also
investigated whether undiagnosed cancer could influence the
personality scores by excluding persons diagnosed with cancer
within the first 3 years. To investigate if other causes of death
beside cancer could influence the results, analyses were performed
on death from all causes as well as on death from cancer
exclusively. We tested possible effect modifications of sex in order
to investigate if personality traits have different effects among men
and women. These tests of effect modification were performed by
including an interaction term for sex and neuroticism in the
analysis. We conducted stratified analyses according to 10-year age
groups to investigate whether an effect of personality could be
related to a specific age group. Finally, we did analyses where the
personality scales were divided into four levels based on quartiles
in order to test if changing the cutoff points would make a
difference in the size of effect.
RESULTS
First, we compared the characteristics of persons according to
extraversion and neuroticism. Persons who scored high on
extraversion were more likely to be male (Po0.01), current
smokers at baseline (P¼0.02), and consumers of alcohol at
baseline (Po0.01). Persons who scored high on neuroticism were
less likely to be male (P¼0.03) and living with their spouse
(P¼0.01) and more likely to be described as neurotic in their
psychiatric status (Po0.01) (Table 1).
In the univariate Cox proportional-hazard regression analyses,
the following six of ten demographic and medical variables
were significantly associated with cancer survival compared
with each referent category (category that showed increased
risk); age in years at cancer diagnosis (continuous variables),
sex (man), cancer site (virus and immune-related organs or
respiratory organs), clinical stage (in situ, regional invasion,
distant metastasis, or unknown), smoking status (past smokers or
current smokers), and alcohol consumption (X151gweek
 1)
(Table 2). Subjects described as neurotic in their psychiatric
status showed an increased and borderline significant (P¼0.053)
risk of death from all causes compared to normal subjects.
Being a theoretically interesting and borderline significant risk
factor for death of all causes, we decided to include it in the further
analyses.
The age and sex adjusted Cox proportional-hazards regression
analysis showed no significant association between extraversion
and the risk of death from all causes among persons diagnosed
with cancer (Table 3). After controlling for age at cancer diagnosis,
sex, cancer site, clinical stage, smoking status, and alcohol
consumption at baseline (in multivariable HR1), the effect of
extraversion on risk of death was basically unchanged (HR, 0.8
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Adding psychiatric status as a confounder in HR2 did not change
the result (Linear trend P¼0.34). The multivariable adjusted HR3
was then estimated excluding 19 persons who were diagnosed as
having cancer within the first 3 years from the baseline, but no
differences in effect were observed for extraversion. The result
when looking exclusively at cancer-related death in HR4 did not
show any significant effect of extroversion (HR, 0.6 (95% CI¼0.3–
1.3); Linear trend P¼0.12).
For neuroticism and the risk of deaths from all causes among
persons diagnosed with cancer, the age and sex adjusted HR
showed no significant association. The multivariable adjusted HR
(HR1) showed a significant association between neuroticism and
the risk of death from all causes (HR, 2.6 (1.4–5.0); Linear trend
Po0.01)). When adding psychiatric status as a confounder the
association remained significant. The multivariable adjusted HR3
was estimated excluding persons diagnosed as having cancer
within the first 3 years from the baseline, but only small differences
in effect were observed (Linear trend P¼0.02). When using cancer
mortality as the end point (case¼69) in HR4, a similar, significant,
linear, positive association between neuroticism and the risk of
death was observed (Linear trend P¼0.04).
We furthermore conducted analyses stratified by sex. No
significant association between extraversion and cancer survival
Table 1 Demographic and medical characteristics according to extraversion and neuroticism in 189 persons diagnosed with cancer
Extraversion Neuroticism
Characteristics p34 – 6X7 P-value p23 – 4X5 P-value
No. of subjects 59 77 53 81 59 49
Age in years at cancer diagnosis, mean7s.d. 55785 4 785 6 77 0.38 55785 5 785 4 78 0.88
Sex (%) o0.01 0.03
M a n 2 03 35 3 4 43 12 3
Woman 80 68 47 56 70 78
Cancer type (%) 0.72
Digestive organs (excluding liver) 12 10 6 9 9 12 0.91
Hormone-related organs
a 24 21 13 20 17 23
Virus and immune-related organs
b 44 43 47 42 53 39
Respiratory organs 10 10 13 14 9 10
Other organs 10 16 21 16 14 16
Clinical stage (%) 0.69 0.11
In situ 14 16 9 11 17 12
Localised 42 40 47 37 46 49
Regional invasion 3 10 13 15 3 6
Distant metastasis 17 13 13 20 14 6
Unknown 24 21 17 17 20 27
Length of education in years (%) 0.60 0.71
o10 75 71 79 72 76 78
X10 25 29 21 28 24 23
Marital status, living with spouse (%) 0.83 0.01
Yes 85 88 87 88 95 76
No 15 12 13 12 8 25
Social class
c (%) 0.12 0.07
I, II 19 16 28 27 19 10
III, IV 28 58 57 51 61 53
V 3 42 61 5 2 22 03 7
Smoking status at baseline (%) 0.02 0.48
Never smokers 46 26 23 35 25 33
Past smokers 15 10 9 15 10 8
Current smokers 39 64 68 51 64 59
Alcohol consumption at baseline (gweek
 1) (%) o0.01 0.21
0 3 12 11 3 1 92 42 4
1–150 58 64 51 60 49 65
X151 12 16 36 21 27 10
Psychiatric status
d o0.01
Normal 81 82 89 0.70 96 90 55
Neurotic 15 16 8 1 8 39
Deviant/psychotic 3 3 4 2 2 6
aIncluding cancers of the breast, corpus uteri, ovary, and prostate.
bIncluding cancers of the skin, non-Hodgkin’s lymphoma, Hodgkin’s disease, leukaemia, liver cancer, and cancer
of the cervix uteri.
cThe social class variable is based on a classification constructed by the Social Research Institute in Denmark and is based on a combination of information on
ownership of land, education, employment status, and number of subordinates. Social group I is the highest social group.
dAs evaluated by the physician who conducted the
social-psychiatric interview.
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swas found among men and women. Among women, neuroticism
was strongly associated with cancer survival in multivariable
adjusted HR2 (Linear trend P¼0.03), and the same pattern was
observed among men although the estimates were not significant.
Also, when including sex and neuroticism as an interaction term,
the associations between neuroticism and the risk of death were
not remarkably modified by sex (P40.05). When stratifying
according to 10-year age groups, cancer type, clinical stage,
smoking, and alcohol consumption, the associations between
neuroticism and the risk of cancer were not remarkably modified.
Also, changing the cutoff points for the personality scales from
tertiles to quartiles did not make any change in effect.
DISCUSSION
This population-based prospective cohort study in Denmark
revealed a significant association between neuroticism and
the risk of death from all causes as well as from cancer-
related death among persons diagnosed with cancer. Stratifi-
cation by gender suggested that the effect was stronger
among women compared with men, but no gender-dependent
effect modification on neuroticism and risk of death was
observed. No significant association was found between
extroversion and risk of death from all causes nor of cancer-
related death.
Table 2 Hazard ratios (HRs) for death from all causes and 95% confidence intervals (CIs) according to demographic and medical characteristics in 189
persons diagnosed with cancer
Univariate analysis
Characteristics No. of subjects Median survival years No. of cases HR (95%CI)
a P-value
Age in years at cancer diagnosis
Continuous variable 189 6 82 1.05 (1.02–1.08) o0.01
Sex
Man 65 3 37 2.0 (1.3–3.0) o0.01
Woman 124 9 45 1.0 (referent)
Cancer type (%)
Digestive organs (excluding liver) 18 4 9 1.0 (referent)
Hormone-related organs
b 37 5 15 0.7 (0.3–1.5) 0.33
Virus and immune-related organs
c 84 12 21 0.4 (0.2–0.8) 0.01
Respiratory organs 21 1 18 3.7 (1.7–8.4) o0.01
Other organs 29 3 19 1.5 (0.7–3.3) 0.31
Clinical stage (%)
In situ 25 26 3 1.0 (referent)
Localised 81 7 24 4.1 (1.2–14.2) 0.02
Regional invasion 17 1 11 18.2 (4.9–68.1) o0.01
Distant metastasis 27 0 27 52.5 (14.9–185.1) o0.01
Unknown 39 6 17 6.7 (1.9–23.9) o0.01
Educational periods in years (%)
o10 141 6 65 1.3 (0.8–2.3) 0.28
X10 48 7 17 1.0 (referent)
Marital status, living with spouse (%)
Yes 164 6 71 1.0 (referent)
No 25 5 11 0.9 (0.5–1.6) 0.64
Social class (%)
I, II 38 4 15 1.0 (referent)
III, IV 103 7 44 1.0 (0.6–1.9) 0.90
V 48 7 23 1.2 (0.6–2.3) 0.57
Smoking status at baseline (%)
Never smokers 59 9 15 1.0 (referent)
Past smokers 22 4 11 2.4 (1.1–5.3) 0.02
Current smokers 108 4 56 2.6 (1.4–4.5) o0.01
Alcohol consumption at baseline (gweek
 1) (%)
0 41 7 15 1.0 (referent)
1–150 110 7 44 1.1 (0.6–1.9) 0.82
X151 38 3 23 2.0 (1.0–3.8) 0.04
Psychiatric status
d
Normal 158 6 65 1.0 (referent)
Neurotic 25 3 15 1.7 (1.0–3.0) 0.053
Deviant/psychotic 6 6 2 0.7 (0.2–2.9) 0.64
aAll hazard ratios (HRs) are given with 95% confidence intervals (CIs) in parentheses.
bIncluding cancers of the breast, corpus uteri, ovary, and prostate.
cIncluding cancers of the
skin, non-Hodgkin’s lymphoma, Hodgkin’s disease, leukaemia, liver cancer, and cancer of the cervix uteri.
dAs evaluated by the physician who conducted the social-psychiatric
interview.
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sFive earlier studies investigated associations between personality
traits using the Eysenck measurements and cancer survival.
Nakaya et al (2005) followed up 890 cases of total cancer for 8
years and documented 356 deaths from all causes. No significant
associations were found for extraversion, neuroticism, psychoti-
cism, or lie. Ratcliffe et al (1995) followed-up 63 cases of Hodgkin’s
disease and non-Hodgkin’s lymphoma for 5 years revealing 27
deaths from all causes. A positive significant, linear association
was observed between lie and the risk of death from all causes
(Linear trend P¼0.001). Dean and Surtees (1989) followed up 121
postoperative cases of breast cancer for 6–8 years revealing 22
deaths from all causes. Extraversion, neuroticism, and lie showed
no significant effect on cancer survival. Hislop et al (1987)
followed-up 133 cases of breast cancer for 4 years revealing 26
deaths from all causes. A significant inverse association was
observed between extraversion and the risk of death from all
causes (multivariate HR¼0.33, Po0.05). Neuroticism was not
associated with risk of death (multivariate HR¼0.85, P40.05).
Lastly, Greer et al (1979) followed-up 69 postoperative cases of
breast cancer for 5 years revealing 18 deaths from all causes. No
significant associations were found for extraversion and neuroti-
cism. The results of the current study indicated that neuroticism
was associated with cancer survival and this association was not
observed in any of the previous studies, only associations between
lie and extroversion and cancer survival was found (Hislop et al,
1987; Ratcliffe et al, 1995). The differences in the results found by
the various studies could be a result of differences in methodo-
logical quality, or perhaps a chance finding.
An association between neuroticism and cancer survival is
theoretically possible and could be related to stress. Studies have
found that neuroticism leads to a high level of psychological
distress (De Jong et al, 1999) and it is possible that stress, through
a dysregulation of the immune system (Maddock and Pariante,
2001; Kiecolt-Glaser et al, 2002), could result in a poor cancer
prognosis. It is also possible that the association is related to
depression. In an earlier study using a population-based sample,
neuroticism was reported to be a significant risk factor for major
depression (Kendler et al, 2004). Furthermore, a number of
prospective studies have reported a statistically significant
association between depression (higher degree of depressive
symptoms or psychiatrically diagnosed depression) and survival
in patients with various types of cancer (Hjerl et al, 2003; Goodwin
et al, 2004). The association between depression and cancer
survival could be explained by potential intermediaries such as
endocrinological or immunological pathways (Pettingale et al,
1981; Kiecolt-Glaser and Glaser, 1999; Spiegel and Kato, 1996), or
by compliance with cancer treatment (Holland, 1987; Colleoni
et al, 2000). Moreover, suicide is also thought to influence survival
from cancer (Akechi et al, 2004; Yousaf et al, 2005).
This study had several methodological advantages compared
with previous studies on personality and cancer survival. First, the
study to the best of our knowledge included the second highest
number of cancer cases and deaths in all of the studies conducted
until now, and analyses were conducted on both death from all
causes and cancer-related deaths. Both measures were important;
ideally cancer-related death should be more accurate, but errors
might be introduced at the assignment of cause of death and
generally the autopsy rate is low; for example, in 1996 the overall
autopsy rate in Denmark was 12.5% (Juel and Helweg-Larsen,
1999). All-cause of death is thus in comparison to cancer-related
death a broader, but more clear and simple end point. Second, we
controlled extensively for potential confounding variables, includ-
ing cigarette smoking and alcohol consumption. A number of
studies have reported that smoking and alcohol consumption are
associated with extraversion and other personality traits (Arai
et al, 1997) as well as with cancer survival (Tammemagi et al,
2004). Comparing point estimates of the HRs for neuroticism in
the univariate and multivariate analyses, we observed differences
Table 3 Hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of all-cause death according to extraversion and neuroticism in 189 persons
diagnosed with cancer
Extraversion Linear trend test
b Neuroticism Linear trend test
a
p34 – 6X7 Linear P-value p23 – 4X5 Linear P-value
Total subjects
No. of death/no. of subjects 27/59 29/77 26/53 35/81 22/59 25/49
Median survival years 4 9 5 5 9 5
Age and sex adjusted HR 1.0 (referent) 0.7 (0.4–1.2) 1.0 (0.5–1.8) 1.0 (0.9–1.1) 0.61 1.0 (referent) 0.9 (05–1.6) 1.5 (0.9–2.6) 1.1 (1.0–1.2) 0.12
Multivariable adjusted HR1 1.0 (referent) 0.5 (0.3–1.0) 0.8 (0.4–1.7) 0.9 (0.8–1.1) 0.33 1.0 (referent) 1.2 (0.6–2.1) 2.6 (1.4–5.0) 1.2 (1.1–1.4) o0.01
Multivariable adjusted HR2 1.0 (referent) 0.6 (0.3–1.0) 0.9 (0.4–1.7) 0.9 (0.8–1.1) 0.34 1.0 (referent) 1.1 (0.6–2.1) 2.3 (1.1–4.7) 1.2 (1.0–1.3) 0.04
Multivariable adjusted HR3 1.0 (referent) 0.6 (0.3–1.1) 0.8 (0.4–1.7) 1.0 (0.8–1.1) 0.38 1.0 (referent) 1.2 (0.6–2.2) 2.6 (1.2–5.4) 1.2 (1.0–1.3) 0.02
Multivariable adjusted HR4 1.0 (referent) 0.5 (0.2–0.9) 0.6 (0.3–1.3) 0.9 (0.8–1.0) 0.12 1.0 (referent) 0.9 (0.4–1.7) 2.2 (1.0–4.8) 1.2 (1.0–1.4) 0.04
Men
No of death/total 8/12 13/25 16/28 19/36 11/18 7/11
Median survival years 2 5 4 4 3 3
Multivariable adjusted HR1 1.0 (referent) 1.3 (0.4–4.2) 1.2 (0.4–4.0) 1.0 (0.8–1.2_ 0.99 1.0 (referent) 1.6 (0.6–4.3) 2.2 (0.6–4.3) 1.2 (1.0–1.2) 0.08
Multivariable adjusted HR2 1.0 (referent) 1.1 (0.3–3.9) 1.2 (0.4–4.1) 1.0 (0.8–1.2) 0.98 1.0 (referent) 1.4 (0.5–4.3) 1.8 (0.5–7.1) 1.2 (0.9–1.5) 0.17
Women
No of death/total 19/47 16/52 10/25 16/45 11/41 18/38
Median survival years 7 11 9 9 9 7
Multivariable adjusted HR1 1.0 (referent) 0.5 (0.2–1.2) 0.7 (0.3–1.9) 0.9 (0.8–1.1) 0.18 1.0 (referent) 0.7 (0.3–2.0) 3.4 (1.4–8.6) 1.3 (1.1–1.5) o0.01
MultivariableHR2 1.0 (referent) 0.5 (0.2–1.2) 0.7 (0.3–1.9) 0.9 (0.8–1.1) 0.18 1.0 (referent) 0.7 (0.2–1.9) 3.2 (1.1–8.7) 1.2 (1.0–1.6) 0.03
Multivariable HR1 was adjusted for age at cancer diagnosis (continuous variable), sex, cancer type (digestive organs, hormone-related organs, virus and immune-related organs,
respiratory organs, or other organs), clinical stage (in situ, localised, regional invasion, distant metastasis, or unknown), smoking status at baseline (never smoker, past smoker, or
current smoker), and alcohol consumption in grams per week at baseline (0, 1–150, or 151 or more). Multivariable HR2 was adjusted for psychiatric status (normal, neurotic, or
deviant/psychotic) in addition to variables adjusted for using multivariable HR1. HR3 was estimated excluding 19 subjects who were diagnosed with cancer within the first 3 years
from baseline and was adjusted for using the same variables as in multivariable HR2. HR4 was estimated with cancer mortality as the end point and was adjusted for using the
same variables as in multivariable HR2.
aLinear trend tests were calculated by treating the personality subscales as continuous variables.
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ssuggesting that smoking and alcohol did affect cancer survival
(Table 2). Also, personality traits were assessed before the cancer
diagnosis, and to the best of our knowledge this has only been
performed in one previous study (Nakaya et al, 2005). Assessing
personality traits after the cancer diagnosis means that the
assessment may have been influenced by the psychological
reactions to the diagnosis or brought about by the treatment. To
assess personality traits before the diagnosis may prevent this type
of bias (Nakaya et al, 2003).
Our study also has some limitations. First, the number of
persons diagnosed as having cancer in the current study
population was small, especially among the men. One would
prefer to stratify by cancer site since the treatment and prognosis
differs for various cancer types. On the other hand, most of the
studies, which in fact provided this kind of site-specific survival
analyses were hampered by small numbers. The analyses may not
have had sufficient statistical power to detect associations between
small increases or decreases in the risk of death from all causes and
personality traits. Also, the confidence limits in this study for the
multivariable analyses on neuroticism among women were broad,
and it is possible that the result was due to chance. Third, we had
no information on health behaviours after the cancer diagnosis
(Kuhn et al, 2005) or on compliance with treatment, which may
have affected survival. Lastly, we lack a detailed theoretical
mechanism explaining why the association between neuroticism
and cancer survival was mainly present among women. It is
possible that the mechanism is connected to depression. In the
current study, the association between neuroticism and cancer
survival was stronger among women. Also, the risk of depression is
higher among women compared with men (Kendler et al, 2004). A
potential explanation for the observed stronger association
between neuroticism and cancer survival among women could
thus be that high neuroticism involves an increased risk of
depression, which may affect the risk of death. Evidence
supporting this hypothesis in the current study is weak since we
found no gender-related effect modification and no deaths were
related to suicide. It would be highly relevant for future research to
include measures of depression in order to shed light on whether
depression can act as a mediating factor.
In conclusion, the results from this population-based prospec-
tive cohort study in Denmark support the hypothesis that
neuroticism is positively associated with cancer survival. Stratifi-
cation by sex suggested that the effect was stronger among women
compared with men, but no gender-related significant effect
modification on neuroticism and risk of all cause or cancer-related
death was observed. Further research on neuroticism and cancer
survival within specific cancer types and including a large
population is needed.
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